B. Metzler Seel. Sohn & Co. Holding Ag Axsome Therapeutics, Inc. Call Options Transaction History
B. Metzler Seel. Sohn & Co. Holding Ag
- $10.1 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AXSM
# of Institutions
326Shares Held
37.7MCall Options Held
912KPut Options Held
855K-
Rtw Investments, LP New York, NY4.19MShares$407 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$388 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$320 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$229 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$101 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.16B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...